Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Johnson & Johnson's Hidden Source Of Value
Seeking Alpha
Wednesday, October 23, 2013 - 6:31pm
tags:
JNJ
Big Pharma Fights Off the Dow's Drop
Motley Fool
Wednesday, October 23, 2013 - 5:01pm
tags:
Merck, Pfizer, MK-5172, MK-8742
3 Catalysts Biocryst Investors Need to Watch
Motley Fool
Wednesday, October 23, 2013 - 4:05pm
tags:
peremivir, Biocryst, BCX4161
Should You Be Excited About This Biotech's Earnings?
Motley Fool
Wednesday, October 23, 2013 - 4:04pm
tags:
Anika, earnings
Biotech volatility can mean danger or opportunity
Marketwatch
Wednesday, October 23, 2013 - 2:40pm
tags:
biotech, EXACT Sciences
Senators To FDA: Has Biosimliar Naming Policy Changed?
Pharmalot
Wednesday, October 23, 2013 - 12:14pm
tags:
biosimilars, FDA, drug names
FDA Slaps Osiris For Misleading Medical Claims About Stem-Cell Bandage
TheStreet.com
Wednesday, October 23, 2013 - 11:42am
tags:
FDA, stem cells, Osiris, Grafix
Analyzing AbbVie Ahead of Its Third-Quarter Earnings
Motley Fool
Wednesday, October 23, 2013 - 11:39am
tags:
AbbVie, earnings
Samsung, Roche in biologics manufacturing deal
Biocentury
Wednesday, October 23, 2013 - 10:13am
tags:
Samsung, Roche, biologics
ViiV Healthcare files new drug application for three-drug HIV pill with US FDA
Pharmaceutical-Technology
Wednesday, October 23, 2013 - 9:57am
tags:
HIV, FDA, ViiV Healthcare, Dolutegravir, abacavir, lamivudine
Bribery scandal slashes GlaxoSmithKline's Chinese drug sales
Yahoo/Reuters
Wednesday, October 23, 2013 - 9:51am
tags:
GSK, China
The Medicines Company Reports Third Quarter 2013 Financial Results
Yahoo
Wednesday, October 23, 2013 - 9:45am
tags:
Medicines Company, earnings
Cubist Pharma takes 3rd-quarter loss on costs from Trius and Optimer deals and other charges
Yahoo/AP
Wednesday, October 23, 2013 - 9:44am
tags:
Cubist Pharma, earnings
Roche CEO would not exclude move into rare diseases
Yahoo/Reuters
Wednesday, October 23, 2013 - 9:42am
tags:
Roche, Severin Schwan, Pharma CEOs
Why Questcor's Latest Clinical Study is a Big Deal
Motley Fool
Wednesday, October 23, 2013 - 9:41am
tags:
Questcor, ARDS, H.P. Acthar Gel
Oxford Nanopore to Let Customers Test Handheld Sequencer
Bloomberg
Wednesday, October 23, 2013 - 9:03am
tags:
Oxford Nanopore, gene sequencing, MinIon, devices
3 Orphan Drugmakers to Watch
Motley Fool
Wednesday, October 23, 2013 - 8:43am
tags:
orphan drugs, Biomarin, GSK, Vimizim, Tafinlar, Mekinist, Myozyme, Cerazyme, Sanofi
Lilly Beats Analyst Estimates on Diabetes Drug Sales
Bloomberg
Wednesday, October 23, 2013 - 8:41am
tags:
Eli Lilly, earnings
Bristol-Myers’s Profit Tops Estimates on Sales Growth
Bloomberg
Wednesday, October 23, 2013 - 8:40am
tags:
Bristol-Myers Squibb, earnings
Biotech Stock Bubble Debate in 14 Charts
TheStreet.com
Wednesday, October 23, 2013 - 8:32am
tags:
biotech, Bluebird Bio, Celgene, Celldex, Onconova, Aegerion, Receptos, Immunomedics, Alcobra, Gilead, Biogen Idec, Ambit Biosciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.